Literature DB >> 12933850

Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium.

Cameron P Simmons1, Simon Clare, Marjan Ghaem-Maghami, Tania K Uren, Joanna Rankin, Allan Huett, Rob Goldin, David J Lewis, Thomas T MacDonald, Richard A Strugnell, Gad Frankel, Gordon Dougan.   

Abstract

Citrobacter rodentium, an attaching-effacing bacterial pathogen, establishes an acute infection of the murine colonic epithelium and induces a mild colitis in immunocompetent mice. This study describes the role of T-cell subsets and B lymphocytes in immunity to C. rodentium. C57Bl/6 mice orally infected with C. rodentium resolved infection within 3 to 4 weeks. Conversely, systemic and colonic tissues of RAG1(-/-) mice orally infected with C. rodentium contained high and sustained pathogen loads, and in the colon this resulted in a severe colitis. C57Bl/6 mice depleted of CD4(+) T cells, but not CD8(+) T cells, were highly susceptible to infection and also developed severe colitis. Mice depleted of CD4(+) T cells also had diminished immunoglobulin G (IgG) and IgA antibody responses to two C. rodentium virulence-associated determinants, i.e., EspA and intimin, despite having a massively increased pathogen burden. Mice with an intact T-cell compartment, but lacking B cells ( micro MT mice), were highly susceptible to C. rodentium infection. Systemic immunity, but not mucosal immunity, could be restored by adoptive transfer of convalescent immune sera to infected micro MT mice. Adoptive transfer of immune B cells, but not naïve B cells, provided highly variable immunity to recipient micro MT mice. The results suggest that B-cell-mediated immune responses are central to resolution of a C. rodentium infection but that the mechanism through which this occurs requires further investigation. These data are relevant to understanding immunity to enteric attaching and effacing bacterial pathogens of humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933850      PMCID: PMC187366          DOI: 10.1128/IAI.71.9.5077-5086.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Site-directed mutagenesis of intimin alpha modulates intimin-mediated tissue tropism and host specificity.

Authors:  S Reece; C P Simmons; R J Fitzhenry; S Matthews; A D Phillips; G Dougan; G Frankel
Journal:  Mol Microbiol       Date:  2001-04       Impact factor: 3.501

2.  Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.

Authors:  M S Donnenberg; C O Tacket; G Losonsky; G Frankel; J P Nataro; G Dougan; M M Levine
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

Review 3.  Immune response to infection with Salmonella typhimurium in mice.

Authors:  H W Mittrücker; S H Kaufmann
Journal:  J Leukoc Biol       Date:  2000-04       Impact factor: 4.962

4.  Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.

Authors:  L J Gansheroff; M R Wachtel; A D O'Brien
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 5.  Immunity to Listeria infection.

Authors:  B T Edelson; E R Unanue
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

Review 6.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Role of EspB in experimental human enteropathogenic Escherichia coli infection.

Authors:  C O Tacket; M B Sztein; G Losonsky; A Abe; B B Finlay; B P McNamara; G T Fantry; S P James; J P Nataro; M M Levine; M S Donnenberg
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology.

Authors:  S C Smelt; S E Cotterell; C R Engwerda; P M Kaye
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

9.  A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation.

Authors:  J M Klapproth; I C Scaletsky; B P McNamara; L C Lai; C Malstrom; S P James; M S Donnenberg
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

10.  Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk.

Authors:  H A Manjarrez-Hernandez; S Gavilanes-Parra; E Chavez-Berrocal; A Navarro-Ocaña; A Cravioto
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

View more
  91 in total

Review 1.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

Review 2.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

3.  Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.

Authors:  Chien-Chang Chen; Steve Louie; Beth McCormick; W Allan Walker; Hai Ning Shi
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  CEACAM1 regulates CD8+ T cell immunity and protects from severe pathology during Citrobacter rodentium induced colitis.

Authors:  Julia Zöller; Jana-Fabienne Ebel; Vishal Khairnar; Verena Schmitt; Robert Klopfleisch; Jana Meiners; Virginia Seiffart; Wiebke Hansen; Jan Buer; Bernhard B Singer; Karl S Lang; Astrid M Westendorf
Journal:  Gut Microbes       Date:  2020-06-10

5.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.

Authors:  Masaru Yoshida; Kanna Kobayashi; Timothy T Kuo; Lynn Bry; Jonathan N Glickman; Steven M Claypool; Arthur Kaser; Takashi Nagaishi; Darren E Higgins; Emiko Mizoguchi; Yoshio Wakatsuki; Derry C Roopenian; Atsushi Mizoguchi; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

6.  IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity.

Authors:  Masaru Yoshida; Atsuhiro Masuda; Timothy T Kuo; Kanna Kobayashi; Steven M Claypool; Tetsuya Takagawa; Hiromu Kutsumi; Takeshi Azuma; Wayne I Lencer; Richard S Blumberg
Journal:  Springer Semin Immunopathol       Date:  2006-10-19

7.  Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits.

Authors:  Karina Ramirez; Rocio Huerta; Eric Oswald; Carlos Garcia-Tovar; Jose Manuel Hernandez; Fernando Navarro-Garcia
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis.

Authors:  Meiqian Weng; Deke Huntley; I-Fei Huang; Ondulla Foye-Jackson; Lijian Wang; Aliese Sarkissian; Qingping Zhou; W Allan Walker; Bobby J Cherayil; Hai Ning Shi
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

9.  Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen.

Authors:  Kirk S B Bergstrom; Julian A Guttman; Mohammad Rumi; Caixia Ma; Saied Bouzari; Mohammed A Khan; Deanna L Gibson; A Wayne Vogl; Bruce A Vallance
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

10.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.